Cargando…
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative Diseases
Diseases of the central nervous system (CNS) have historically been among the most difficult to treat using conventional pharmacological approaches. This is due to a confluence of factors, including the limited regenerative capacity and overall complexity of the brain, problems associated with repea...
Autores principales: | Rittiner, Joseph Edward, Moncalvo, Malik, Chiba-Falek, Ornit, Kantor, Boris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437156/ https://www.ncbi.nlm.nih.gov/pubmed/32903507 http://dx.doi.org/10.3389/fnmol.2020.00148 |
Ejemplares similares
-
APOE: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s
por: Yang, Anna, et al.
Publicado: (2021) -
Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer’s disease
por: Angrist, Misha, et al.
Publicado: (2020) -
Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders
por: Gamache, Julia, et al.
Publicado: (2020) -
Bioinformatics pipeline to guide late‐onset Alzheimer's disease (LOAD) post‐GWAS studies: Prioritizing transcription regulatory variants within LOAD‐associated regions
por: Lutz, Michael W., et al.
Publicado: (2022) -
Probing the role of PPARγ in the regulation of late-onset Alzheimer’s disease-associated genes
por: Barrera, Julio, et al.
Publicado: (2018)